FIELD: pharmacology.
SUBSTANCE: antimicrobial composition for use in otorhinolaryngology containing hydroxymethylquinoxaline dioxide, polyvinylpyrrolidone and dexamethasone is described, with the following component ratio, wt %: polyvinylpyrrolidone 45.0-55.0, hydroxymethylquinoxaline dioxide solution 10 mg/ml 30.0-33.0, dexamethasone solution 4 mg/ml 12.0-25.0.
EFFECT: antimicrobial composition has a prolonged action due to its high viscosity and adsorption capacity, providing long-term exposure to active substances and reducing the incidence of invasive procedures in otorhinolaryngology.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG COMPOSITION WITH REGENERATIVE AND ANTIBACTERIAL PROPERTIES FOR THE PREVENTION OF POSTOPERATIVE COMPLICATIONS IN RHINOLOGY | 2022 |
|
RU2792597C1 |
| METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 |
|
RU2600645C2 |
| METHOD OF TREATMENT OF CHRONIC PURULENT RHINOSINUSITIS | 2007 |
|
RU2345784C1 |
| METHOD OF POLYPOUS RHINOSINUSITIS TREATMENT | 2017 |
|
RU2646806C1 |
| METHOD FOR OBTAINING MATERIAL FROM THE MAXILLARY SINUS FOR MICROBIOLOGICAL EXAMINATION IN PATIENTS WITH CYSTIC FIBROSIS WHO UNDERWENT ENDOSCOPIC SURGICAL TREATMENT FOR CHRONIC RHINOSINUSITIS | 2022 |
|
RU2794083C1 |
| METHOD TO TREAT CHRONIC PURULENT RHINOSINUSITIS | 2001 |
|
RU2178676C1 |
| METHOD FOR TREATING CHRONIC RHINOSINUSITIS | 2021 |
|
RU2781348C1 |
| METHOD FOR PURULENT-INFLAMMATORY DISEASES OF PARANASAL SINUSES | 2004 |
|
RU2268048C1 |
| METHOD OF CLINICAL EFFECTIVENESS IN PATIENTS WITH CHRONIC CONDITIONS OF NOSE AND ACCESSORY SINUSES OF NOSE | 2010 |
|
RU2431834C1 |
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
